2023 Q2 Form 10-Q Financial Statement

#000181864423000006 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $571.0K $636.0K
YoY Change -19.12% -41.22%
Cost Of Revenue $1.911M $2.261M
YoY Change 33.92% 52.56%
Gross Profit -$1.340M -$1.625M
YoY Change 85.85% 306.25%
Gross Profit Margin -234.68% -255.5%
Selling, General & Admin $8.949M $14.82M
YoY Change -40.93% -7.05%
% of Gross Profit
Research & Development $5.897M $9.442M
YoY Change -45.21% 10.1%
% of Gross Profit
Depreciation & Amortization $336.0K $330.0K
YoY Change 31.76% 58.65%
% of Gross Profit
Operating Expenses $14.85M $24.26M
YoY Change -42.71% -1.05%
Operating Profit -$16.19M -$25.89M
YoY Change -39.23% 3.88%
Interest Expense $185.0K -$533.0K
YoY Change -62.32% -235.97%
% of Operating Profit
Other Income/Expense, Net $174.0K -$357.0K
YoY Change -5.43% -828.57%
Pretax Income -$16.01M -$26.25M
YoY Change -39.46% 5.52%
Income Tax $19.00K $19.00K
% Of Pretax Income
Net Earnings -$16.03M -$26.27M
YoY Change -39.43% 5.56%
Net Earnings / Revenue -2807.53% -4129.72%
Basic Earnings Per Share -$0.09 -$0.16
Diluted Earnings Per Share -$0.09 -$0.16
COMMON SHARES
Basic Shares Outstanding 176.9M shares 168.8M shares
Diluted Shares Outstanding 175.7M shares 165.9M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.65M $74.09M
YoY Change -53.36% -48.49%
Cash & Equivalents $18.39M $20.50M
Short-Term Investments $40.26M $53.59M
Other Short-Term Assets $109.0K $320.0K
YoY Change -49.07% -68.84%
Inventory $4.913M $4.695M
Prepaid Expenses $1.728M $2.039M
Receivables $290.0K $123.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $67.15M $82.44M
YoY Change -50.32% -46.1%
LONG-TERM ASSETS
Property, Plant & Equipment $7.783M $7.902M
YoY Change 15.87% 39.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.235M $2.438M
YoY Change 467.85% 119.84%
Total Long-Term Assets $28.77M $27.64M
YoY Change 10.0% 10.96%
TOTAL ASSETS
Total Short-Term Assets $67.15M $82.44M
Total Long-Term Assets $28.77M $27.64M
Total Assets $95.92M $110.1M
YoY Change -40.54% -38.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.520M $2.209M
YoY Change -8.24% 13.17%
Accrued Expenses $9.020M $9.646M
YoY Change -16.42% 7.24%
Deferred Revenue $150.0K $476.0K
YoY Change -90.81% -74.3%
Short-Term Debt $1.641M $5.384M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.33M $17.72M
YoY Change -11.87% 38.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $44.00K $112.0K
YoY Change -4.35% -76.91%
Total Long-Term Liabilities $44.00K $112.0K
YoY Change -4.35% -76.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.33M $17.72M
Total Long-Term Liabilities $44.00K $112.0K
Total Liabilities $30.26M $34.11M
YoY Change -10.28% 11.46%
SHAREHOLDERS EQUITY
Retained Earnings -$292.8M -$276.8M
YoY Change 44.14% 56.66%
Common Stock $18.00K $17.00K
YoY Change 12.5% 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $65.66M $75.97M
YoY Change
Total Liabilities & Shareholders Equity $95.92M $110.1M
YoY Change -40.54% -38.11%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$16.03M -$26.27M
YoY Change -39.43% 5.56%
Depreciation, Depletion And Amortization $336.0K $330.0K
YoY Change 31.76% 58.65%
Cash From Operating Activities -$15.25M -$17.20M
YoY Change -10.76% 7.31%
INVESTING ACTIVITIES
Capital Expenditures $209.0K $599.0K
YoY Change -121.22% -22.61%
Acquisitions
YoY Change
Other Investing Activities $13.87M $22.08M
YoY Change 29.22% 42.43%
Cash From Investing Activities $13.66M $21.48M
YoY Change 40.13% 45.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.670M -$2.845M
YoY Change -769.17% 66.47%
NET CHANGE
Cash From Operating Activities -15.25M -$17.20M
Cash From Investing Activities 13.66M $21.48M
Cash From Financing Activities -2.670M -$2.845M
Net Change In Cash -4.259M $1.437M
YoY Change -38.64% -147.8%
FREE CASH FLOW
Cash From Operating Activities -$15.25M -$17.20M
Capital Expenditures $209.0K $599.0K
Free Cash Flow -$15.46M -$17.79M
YoY Change -4.01% 5.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001818644
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-259554
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AEye, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1827430
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One Park Place
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94568
CY2023Q1 dei City Area Code
CityAreaCode
(925)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
400-4366
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
176891993 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20501000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19064000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
53592000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
75135000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
123000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
617000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
4695000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4553000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3527000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6181000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
82438000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
105550000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15152000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15502000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7902000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7665000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2150000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2150000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2438000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2473000 usd
CY2023Q1 us-gaap Assets
Assets
110080000 usd
CY2022Q4 us-gaap Assets
Assets
133340000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2209000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3218000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9646000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9764000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
476000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
987000 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
5384000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
8594000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
17715000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22563000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16287000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16681000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
112000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
126000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
34114000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
39370000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
170969581 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
170969581 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
163099124 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163099124 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
16000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
353533000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
345742000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-810000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1279000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-276774000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250509000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
75966000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
93970000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110080000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133340000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
636000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1082000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
2261000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
424000 usd
CY2023Q1 lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
-176000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1482000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-1625000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
-400000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9442000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8576000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6268000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4616000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8554000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11330000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
24264000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
24522000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25889000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-24922000 usd
CY2023Q1 lidr Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
-810000 usd
CY2022Q1 lidr Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
-32000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
277000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24881000 usd
CY2022Q1 lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
343000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-357000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
49000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-26265000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24881000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165865864 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165865864 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155515093 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155515093 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-26265000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
490000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1056000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
-21000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25796000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25937000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
93970000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6513000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
391000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
867000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1755000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
469000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-26265000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
75966000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
168767000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5340000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
222000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1149000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1056000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24881000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
147243000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-26265000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24881000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
330000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
208000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
53000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
350000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
317000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
208000 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
267000 usd
CY2023Q1 lidr Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
-810000 usd
CY2022Q1 lidr Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
-32000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6513000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5340000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-33000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-594000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-494000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3930000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
386000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
436000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2722000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-510000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-71000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-400000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-985000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-567000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-134000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-645000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-392000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-325000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-511000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-767000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17195000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16023000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
599000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
774000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
76000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
22000000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
15500000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
21477000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14726000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
323000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
222000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
868000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1931000 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2300000 usd
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2845000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1709000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1437000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3006000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21214000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16333000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22651000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13327000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
85000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
260000 usd
CY2023Q1 lidr Proceeds From Exercise Of Stock Options Included In Prepaid And Other Current Assets
ProceedsFromExerciseOfStockOptionsIncludedInPrepaidAndOtherCurrentAssets
68000 usd
CY2022Q1 lidr Proceeds From Exercise Of Stock Options Included In Prepaid And Other Current Assets
ProceedsFromExerciseOfStockOptionsIncludedInPrepaidAndOtherCurrentAssets
0 usd
CY2023Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1755000 usd
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
CY2023Q1 lidr Tax Withholding Accrued Share Based Payment Arrangement
TaxWithholdingAccruedShareBasedPaymentArrangement
3000 usd
CY2022Q1 lidr Tax Withholding Accrued Share Based Payment Arrangement
TaxWithholdingAccruedShareBasedPaymentArrangement
53000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:0.12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and marketable securities, and accounts receivable. The Company places its cash and cash equivalents with major financial institutions, which management assesses to be of high credit quality, to limit the exposure of each investment. The Company’s marketable securities have investment grade ratings when purchased which mitigates risk.</span></div><div style="margin-bottom:0.12pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivables are derived from customers located in the U.S., Europe, and Asia. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company generally does not require collateral.</span></div>
CY2023Q1 lidr Class Of Warrant Or Right Term Of Contract
ClassOfWarrantOrRightTermOfContract
P4Y
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8713000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
4055000 usd
CY2023Q1 lidr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Income Expense
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherIncomeExpense
-808000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
-21000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5487000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1842000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2022000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2804000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2484000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
49000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
47000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
4695000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4553000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
1527000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1491000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
273000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
833000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2039000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4203000 usd
CY2023Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
986000 usd
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
984000 usd
CY2023Q1 lidr Demonstration Units Current
DemonstrationUnitsCurrent
182000 usd
CY2022Q4 lidr Demonstration Units Current
DemonstrationUnitsCurrent
281000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
320000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
713000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3527000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6181000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
602000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
577000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
79000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
63000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
681000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
640000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1889000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2570000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2583000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2660000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2701000 usd
CY2023Q1 lidr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
11116000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
23519000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4775000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18744000 usd
CY2023Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
188000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1082000 usd
CY2022Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-336000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
12000 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000 usd
CY2023Q1 lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
-176000 usd
CY2022Q1 lidr Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
343000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
469000 usd
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-1056000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-26265000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24881000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165865864 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155515093 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165865864 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155515093 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67911894 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
50024185 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6513000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5340000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.045
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.048
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
636000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1082000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
636000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
476000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
476000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
987000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2918000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
511000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
767000 usd
CY2023Q1 lidr Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied
ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied
0 usd
CY2022Q1 lidr Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied
ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied
0 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
476000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2151000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1253000 usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1253000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001818644-23-000006-index-headers.html Edgar Link pending
0001818644-23-000006-index.html Edgar Link pending
0001818644-23-000006.txt Edgar Link pending
0001818644-23-000006-xbrl.zip Edgar Link pending
exhibit101amendedandrest.htm Edgar Link pending
exhibit101amendedandrest001.jpg Edgar Link pending
exhibit101amendedandrest002.jpg Edgar Link pending
exhibit101amendedandrest003.jpg Edgar Link pending
exhibit101amendedandrest004.jpg Edgar Link pending
exhibit101amendedandrest005.jpg Edgar Link pending
exhibit101amendedandrest006.jpg Edgar Link pending
exhibit101amendedandrest007.jpg Edgar Link pending
exhibit101amendedandrest008.jpg Edgar Link pending
exhibit101amendedandrest009.jpg Edgar Link pending
exhibit101amendedandrest010.jpg Edgar Link pending
exhibit101amendedandrest011.jpg Edgar Link pending
exhibit101amendedandrest012.jpg Edgar Link pending
exhibit101amendedandrest013.jpg Edgar Link pending
exhibit101amendedandrest014.jpg Edgar Link pending
exhibit101amendedandrest015.jpg Edgar Link pending
exhibit101amendedandrest016.jpg Edgar Link pending
exhibit101amendedandrest017.jpg Edgar Link pending
exhibit101amendedandrest018.jpg Edgar Link pending
exhibit101amendedandrest019.jpg Edgar Link pending
exhibit101amendedandrest020.jpg Edgar Link pending
exhibit101amendedandrest021.jpg Edgar Link pending
exhibit101amendedandrest022.jpg Edgar Link pending
exhibit101amendedandrest023.jpg Edgar Link pending
exhibit101amendedandrest024.jpg Edgar Link pending
exhibit101amendedandrest025.jpg Edgar Link pending
exhibit101amendedandrest026.jpg Edgar Link pending
exhibit101amendedandrest027.jpg Edgar Link pending
exhibit101amendedandrest028.jpg Edgar Link pending
exhibit101amendedandrest029.jpg Edgar Link pending
exhibit101amendedandrest030.jpg Edgar Link pending
exhibit101amendedandrest031.jpg Edgar Link pending
exhibit101amendedandrest032.jpg Edgar Link pending
exhibit101amendedandrest033.jpg Edgar Link pending
exhibit101amendedandrest034.jpg Edgar Link pending
exhibit101amendedandrest035.jpg Edgar Link pending
exhibit101amendedandrest036.jpg Edgar Link pending
exhibit101amendedandrest037.jpg Edgar Link pending
exhibit101amendedandrest038.jpg Edgar Link pending
exhibit101amendedandrest039.jpg Edgar Link pending
exhibit101amendedandrest040.jpg Edgar Link pending
exhibit101amendedandrest041.jpg Edgar Link pending
exhibit101amendedandrest042.jpg Edgar Link pending
exhibit101amendedandrest043.jpg Edgar Link pending
exhibit101amendedandrest044.jpg Edgar Link pending
exhibit311ceosection302cer.htm Edgar Link pending
exhibit312cfosection302cer.htm Edgar Link pending
exhibit321section906certif.htm Edgar Link pending
exhibit32amendmentofcertif.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lidr-20230331.htm Edgar Link pending
lidr-20230331.xsd Edgar Link pending
lidr-20230331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
lidr-20230331_cal.xml Edgar Link unprocessable
lidr-20230331_def.xml Edgar Link unprocessable
lidr-20230331_lab.xml Edgar Link unprocessable
lidr-20230331_pre.xml Edgar Link unprocessable
lidr-20230331_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending